Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues
Related Experiment Video
Updated: Jan 19, 2026
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
Stela Vujosevic1, Ferdinando Martini, Enrica Convento
1Department of Ophthalmology University of Padova, Padova, Italy.
Purpose:
To review the most important metabolic effects and clinical safety data of subthreshold micropulse diode laser (D-MPL) in diabetic macular edema (DME).
Methods:
Review of the literature about the mechanisms of action and role of D-MPL in DME.
Results:
The MPL treatment does not damage the retina and is selectively absorbed by the retinal pigment epithelium (RPE). MPL stimulates secretion of different protective cytokines by the RPE. No visible laser spots on the retina were noted on any fundus image modality in different studies, and there were no changes of the outer retina integrity. Mean central retinal sensitivity (RS) increased in subthreshold micropulse diode laser group compared to standard ETDRS photocoagulation group.
Conclusions:
MPL is a new, promising treatment option in DME, with both infrared and yellow wavelengths using the less aggressive duty cycle (5%) and fixed power parameters. It appears to be safe from morphologic and functional point of view in mild center involving DME.
Insights
Subthreshold micropulse diode laser (D-MPL) offers a safe and effective treatment for diabetic macular edema (DME). This method preserves retinal integrity and improves visual function without visible damage.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Laser Therapy
Background:
- Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
- Current treatments for DME have limitations and potential side effects.
Purpose of the Study:
- To review the metabolic effects and clinical safety of subthreshold micropulse diode laser (D-MPL) for DME.
- To evaluate D-MPL's role in managing diabetic macular edema.
Main Methods:
- Literature review focusing on D-MPL mechanisms and efficacy in DME.
- Analysis of studies examining D-MPL's safety and functional outcomes.
Main Results:
- D-MPL treatment is selectively absorbed by the retinal pigment epithelium (RPE) without causing retinal damage.
- MPL stimulates protective cytokine secretion by the RPE, enhancing retinal health.
- No visible laser spots or outer retina integrity changes were observed; central retinal sensitivity improved compared to standard photocoagulation.
Conclusions:
- Subthreshold micropulse diode laser (MPL) presents a promising, safe treatment for mild center-involving DME.
- MPL, utilizing specific wavelengths and parameters, demonstrates favorable morphologic and functional safety.
- This laser therapy offers a less aggressive alternative for managing diabetic macular edema.
